Download presentation
Presentation is loading. Please wait.
Published byDavid Gill Modified over 11 years ago
1
Progress Against Lymphoma
2
1970–1979
3
Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy
4
Progress Against Lymphoma 1970–1979 1975: New chemotherapy regimen boosts Hodgkin lymphoma cure rates to 70 percent 1975: Era of bone marrow transplantation begins – extending lives of many patients with leukemia and lymphoma
5
Progress Against Lymphoma 1970–1979 1976: CHOP regimen boosts cure rates for non- Hodgkin lymphoma
6
Progress Against Lymphoma 1980–1989
7
Progress Against Lymphoma 1980–1989 1980: Imaging tests begin replacing surgery for Hodgkin lymphoma staging
8
Progress Against Lymphoma 1980–1989 Late 1980s: Benzene established to cause blood cancers
9
Progress Against Lymphoma 1990–1999
10
Progress Against Lymphoma 1990–1999 1993: Mantle cell lymphoma recognized as a subtype of non-Hodgkin lymphoma
11
Progress Against Lymphoma 1990–1999 1990s: Research suggests a therapeutic vaccine for follicular lymphoma could be possible 1995: Lymphocyte transfusions re-induce leukemia remissions 1995: Bone marrow transplantation improves survival for relapsed non-Hodgkin lymphoma
12
Progress Against Lymphoma 1990–1999 1997: FDA approves first-ever targeted cancer drug, rituximab 1997: Classification system established for non- Hodgkin lymphoma
13
Progress Against Lymphoma 1990–1999 1998: New technique enables older patients to undergo life-saving stem cell transplants
14
Progress Against Lymphoma 2000–Present
15
Progress Against Lymphoma 2000–Present 2001: Scientists discover that common type of lymphoma is two distinct diseases
16
Progress Against Lymphoma 2000–Present 2002: Adding rituximab to ''CHOP'' chemotherapy boosts survival 2002: Radioimmunotherapy introduced to treat lymphoma
17
Progress Against Lymphoma 2000–Present 2005: Bortezomib shrinks tumors in mantle cell lymphoma
18
Progress Against Lymphoma 2000–Present 2007: PET scanning helps guide lymphoma treatment
19
Progress Against Lymphoma 2000–Present 2008: First drug approved specifically for T-cell lymphoma treatment
20
Progress Against Lymphoma Five-Year Survival Source: National Cancer Institute
21
Progress Against Lymphoma Mortality Source: National Cancer Institute
22
Progress Against Lymphoma New Cases Source: National Cancer Institute
23
Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.